Boomi CEO Steve Lucas Releases New Book: Digital Impact — The Human Element of AI-Driven Transformation
15.4.2025 15:00:00 CEST | Business Wire | Press Release
Boomi, the intelligent integration and automation leader, today announced the release of Digital Impact: The Human Element of AI-Driven Transformation (Wiley), a bold new book by Boomi Chairman and CEO Steve Lucas. In it, Lucas makes a powerful case for a problem few business leaders are talking about: the AI revolution is doomed to stall unless we first fix the broken digital infrastructure that supports it.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250415679642/en/
Boomi CEO Steve Lucas Releases New Book: Digital Impact — The Human Element of AI-Driven Transformation
With nearly 30 years of leadership at companies including Adobe, SAP, Salesforce, and Marketo, Lucas shares a firsthand playbook for addressing the crisis of digital fragmentation — outdated systems, disconnected data, and chaotic architectures — that threatens to derail enterprise AI.
“AI is only as smart as the systems and data it runs on,” said Lucas. “Right now, most companies are trying to build AI skyscrapers on sand. But with the right integration strategy — one that puts people first — we can turn digital chaos into a catalyst for innovation, sustainability, and human progress.”
Featuring exclusive interviews with enterprise leaders and a foreword on the coming AI era, Digital Impact provides a roadmap for creating connected, intelligent, and human-centered digital environments. The book introduces Lucas’s “Digital Impact Mission,” a new leadership framework that calls on CEOs to lead transformation from the top, fix fragmentation first, and prioritize technology that empowers people.
Praise for Digital Impact from business luminaries includes:
“Every industry, every company, every workflow is being reinvented with AI. Organizations face the monumental task of embracing the opportunity in this transformative moment. Digital Impact provides a blueprint for navigating the AI revolution.”
— Bill McDermott, CEO, ServiceNow
“Embracing AI is now an imperative for businesses seeking a step-function change in productivity. Digital Impact compels you to reject fear of the unknown and turn AI into one of your most transformational business assets.”
— Carl Eschenbach, CEO, Workday
“People don’t yet understand how important integrating systems and data will be to succeeding in the age of AI. Digital Impact will help you leave your competitors in the dust.”
— Betsy Atkins, former Chairman and CEO, Clear Standards, Inc.
“Business, like sports, needs an innovative game plan to keep you ahead of the competition. Digital Impact provides real-world examples and practical advice for how you can win your game.”
— Jonathan Becher, President, San Jose Sharks Sports & Entertainment
Digital Impact also explores compelling case studies, from banks modernizing legacy data systems to global logistics companies building real-time supply chain intelligence and not-for-profits using connected tech to drive change.
Available today, Digital Impact: The Human Element of AI-Driven Transformation is a must-read for any leader looking to unlock the full power of AI by building a smarter, more connected digital foundation — one designed with people and purpose at the center.
To learn more, visit:www.boomi.com/digitalimpact
About Boomi
Boomi, the intelligent integration and automation leader, helps organizations around the world automate and streamline critical processes to achieve business outcomes faster. Harnessing advanced AI capabilities, the Boomi Enterprise Platform seamlessly connects systems and manages data flows with API management, integration, data management, and AI orchestration in one comprehensive solution. With over 23,000 customers globally and a rapidly expanding network of 800+ partners, Boomi is revolutionizing the way enterprises of all sizes achieve business agility and operational excellence. Discover more at boomi.com.
© 2025 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250415679642/en/
Contacts
Media:
Kristen Walker | (415) 613-8320 | kristenwalker@boomi.com
David Wolpert | (972) 743-8477 | david@fortierpr.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom